Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pareto8020on Jun 14, 2022 7:20am
126 Views
Post# 34754283

RE:Post DEAL Interview

RE:Post DEAL InterviewSo they do a company making deal and don't release any numbers so the market or anyone can evaulate it?  R you f'n kidding me??!!!

"Let’s talk numbers. Can you elaborate on the actual figures? HV: Do you see this smile on my face? I can assure everyone that AbbVie is rewarding Sirona Biochem appropriately for our breakthrough technology. Although I am contractually bound to not comment on how much we are receiving, suffice it to say that it will be substantial given that we are getting royalty payments on the global sales of AbbVie’s products based on our patents."

That smile isn't worth a dime Howard - release the numbers you incompentent CEO!!!  This is honestly mind blowing - I can't believe they are going to sit on the numbers and even agreed to not release them?  Wouldn't the financial information be deemed "material" for crying out loud?  OMG I can't wait until this finally takes off so I can exit the hell out of here and stop looking at HV's idiotic face.    
<< Previous
Bullboard Posts
Next >>